Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Sun Myint A, Rao C, Barbet N, Thamphya B, Pace-Loscos T, Schiappa R, Magné N, Martel-Lafay I, Mineur L, Deberne M, Zilli T, Dhadda A, Gerard JP. Sun Myint A, et al. Among authors: barbet n. Colorectal Dis. 2023 Nov;25(11):2160-2169. doi: 10.1111/codi.16773. Epub 2023 Oct 13. Colorectal Dis. 2023. PMID: 37837240 Clinical Trial.
'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
Mitrea D, Barbet N, Pacé-Loscos T, Scouarnec C, Ben-Dhia S, Baron D, Mineur L, Évesque L, Durand-Labrunie J, Gérard JP, Baudin G, Doyen J. Mitrea D, et al. Among authors: barbet n. Cancer Radiother. 2024 Aug;28(4):323-332. doi: 10.1016/j.canrad.2024.02.003. Epub 2024 Jul 14. Cancer Radiother. 2024. PMID: 39003168
Reproducibility of surface-based deep inspiration breath-hold technique for lung stereotactic body radiotherapy on a closed-bore gantry linac.
Nguyen D, Reinoso R, Farah J, Yossi S, Lorchel F, Passerat V, Louet E, Pouchard I, Khodri M, Barbet N. Nguyen D, et al. Among authors: barbet n. Phys Imaging Radiat Oncol. 2023 May 13;26:100448. doi: 10.1016/j.phro.2023.100448. eCollection 2023 Apr. Phys Imaging Radiat Oncol. 2023. PMID: 37252251 Free PMC article.
A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial.
Baron D, Pace Loscos T, Schiappa R, Barbet N, Dost E, Ben Dhia S, Soltani S, Mineur L, Martel I, Horn S, Picardi C, Stewart A, Cotte E, Coquard R, Baudin G, Evesque L, Dhadda A, Sun Myint A, Gérard JP, Doyen J; ICONE group. Baron D, et al. Among authors: barbet n. Ann Oncol. 2024 Nov 10:S0923-7534(24)04904-4. doi: 10.1016/j.annonc.2024.10.827. Online ahead of print. Ann Oncol. 2024. PMID: 39532203
Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.
Gerard JP, Barbet N, Schiappa R, Magné N, Martel I, Mineur L, Deberne M, Zilli T, Dhadda A, Myint AS; ICONE group. Gerard JP, et al. Among authors: barbet n. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):356-367. doi: 10.1016/S2468-1253(22)00392-2. Epub 2023 Feb 16. Lancet Gastroenterol Hepatol. 2023. PMID: 36801007 Clinical Trial.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study.
Lorchel F, Nguyen D, Mamou A, Barbet N, Camoesas J, Degluaire Y, Pouchard I, Queffelec Y, Renoult F, Khodri M, Farah J. Lorchel F, et al. Among authors: barbet n. Clin Transl Radiat Oncol. 2022 May 18;35:90-96. doi: 10.1016/j.ctro.2022.05.002. eCollection 2022 Jul. Clin Transl Radiat Oncol. 2022. PMID: 35662884 Free PMC article.
Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.
Gerard JP, Myint AS, Barbet N, Dejean C, Thamphya B, Gal J, Montagne L, Vuong T. Gerard JP, et al. Among authors: barbet n. Cancers (Basel). 2022 Mar 3;14(5):1313. doi: 10.3390/cancers14051313. Cancers (Basel). 2022. PMID: 35267621 Free PMC article.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
47 results